Non-Invasive Cervical VNS for Headache

Core topics

Lessons in this module

Learning objectives

By the end of this module you will be able to

Lesson summary ↓Graded claims ↓Self-check ↓Vignettes ↓Glossary ↓

L01
Identify the FDA-cleared headache indications for cervical nVNS (acute/preventive migraine ≥12y, acute episodic cluster, adjunctive cluster prevention).
L02
Describe the device mechanics and a typical 2-minute neck-application session.
L03
Position nVNS for triptan-ineligible patients or those seeking non-pharmacologic options.
L04
Quote realistic effect sizes and the variability across PRESTO/EVENT/ACT trials.
L05
Counsel patients on prescription/rental access models.

Expected takeaways

What you should walk away believing

→Cluster headache (acute) has the strongest nVNS evidence.
→Effect sizes for migraine are modest but real for some patients.
→Side effects are mostly mild and local.
→nVNS is an option, not a triptan replacement.

Lesson · Core emphasis

What this means for you

Patient summary

gammaCore is a handheld device you press to your neck for a couple of minutes. It's approved for certain migraines and cluster headaches and can help some people avoid or reduce medication use — but it doesn't work for everyone, and effect sizes are modest.

Clinician summary

Indications: acute & preventive migraine (≥12y), acute episodic cluster, adjunctive cluster prevention. Effect sizes modest; consider in patients seeking non-pharm options, those with med contraindications (e.g., triptan-ineligible cardiovascular patients), or as part of multimodal regimens. Counsel on prescription/rental model and realistic expectations.

Advanced note

Mechanism likely involves trigeminocervical complex modulation via vagal afferents and brainstem connectivity. Trial heterogeneity (PRESTO, EVENT, ACT1/2) complicates effect-size estimates; HTAs (e.g., NICE, CADTH) note mixed certainty.

Evidence framework

Where this module sits on the device evidence map

gammaCore is Tier 2 (FDA-cleared with multiple RCTs); evidence varies by indication.

Tier map →Tier 2 →

Evidence-graded claims

What the data says

A

nVNS is FDA-cleared for acute episodic cluster headache

Established indication.

F

nVNS is uniformly effective across all headache types

Evidence varies by indication; HTAs note mixed certainty.

B

nVNS has a favorable safety profile vs many headache medications

Mostly mild local AEs.

F

nVNS replaces triptans in acute migraine

Adjunctive or alternative; not equivalent.

B

nVNS provides cluster prevention benefit as adjunct

Trial-supported in episodic cluster.

Objective self-check

Test the learning objectives

Score0 / 3(0 answered)

Objective · FDA-cleared headache indications.

Q1L01 — Strongest nVNS headache indication by evidence?

Objective · Device mechanics.

Q2L02 — gammaCore is best described as:

Objective · Realistic effect-size counseling.

Q3L03 — Patient with chronic migraine asks if nVNS will eliminate headaches. Best framing?

Case vignettes

Apply it: real-world counseling scenarios

Short patient encounters that test your judgment, not your recall. Pick the most defensible response, then reveal the rationale and a sample coaching script you could actually say at the bedside.

Vignette proficiency

In progress · 0/3 submitted

Correct0/3 (0%)Pitfalls avoided0/5 (0%)Composite0

Composite weighting

Accuracy 60%Pitfalls 40%

← all pitfallsbalancedall accuracy →

Composite = 60% answer accuracy + 40% pitfalls avoided. Your weighting is saved for this module.

Order · randomized[1 · 2 · 3]

Vignette 1 of 3· source #1

Acute episodic cluster patient

Objective · Identify the FDA-cleared headache indications for nVNS.

A 41-year-old with episodic cluster headache, currently in a cluster bout, asks about gammaCore.

Most defensible recommendation?

Vignette 2 of 3· source #2

Migraine patient with CV disease

Objective · Position nVNS for triptan-ineligible patients.

A 58-year-old with chronic migraine and a history of MI cannot take triptans. He asks about non-pharmacologic options.

Best framing?

Vignette 3 of 3· source #3

Tension headache request

Objective · Quote realistic effect sizes and indication scope.

A patient with chronic tension-type headache asks if nVNS will help.

Most accurate response?

Quick check

Test yourself

Q1gammaCore is an example of:

Q2Strongest nVNS headache indication?

Q3Best counseling for a patient with chronic migraine considering nVNS?

Flashcards

Lock it in

1 / 5

Front

What is gammaCore?

Click to flip

Glossary

Key terms & abbreviations

nVNS: Non-invasive cervical vagus nerve stimulation, applied at the side of the neck.
gammaCore: FDA-cleared handheld nVNS device for migraine and cluster headache indications.
Trigeminocervical complex: Brainstem convergence of trigeminal and upper cervical afferents; modulated by vagal input.
Triptan: Serotonin 5-HT1B/1D agonist for acute migraine; CV contraindications make nVNS attractive in some patients.
PRESTO / EVENT / ACT trials: nVNS trials in migraine and cluster headache; effect sizes vary across endpoints and populations.
HTA: Health Technology Assessment (e.g. NICE, CADTH); often note mixed certainty for nVNS.
Multimodal headache regimen: Combining acute, preventive, and non-pharmacologic strategies — where nVNS often fits.